HiXT7
| Catalog No. | ON-1078 |
| Purity | ＞95% by SDS-PAGE |
| Storage Condition | -20℃ |
| Source | Recombinant E.coli |
HiXT7
HiXT7 - M (Molecular Biology) / GMP/Non-GMP is backordered and will ship as soon as it is back in stock.
Couldn't load pickup availability
Shipping notes
Shipping notes
Details
Details
Product Information
HiXT7 RNA Polymerase is a DNA-dependent RNA polymerase designed to increase co-transcriptional capping efficiency and reduce double-stranded RNA formation during IVT, enabling the production of high-quality, clean mRNA transcripts. This optimized enzyme is specifically suited for use with HiXCap E1, HiXCap E2, HiXCap E3 and M6 GAAG Cap2 cap analogs, delivering superior 5’-end capping performance compared with wild-type T7 RNA polymerase. The enzyme is fully compatible with 5×HIC IVT Reaction Buffer, and supports up to 100 µg of high-quality capped RNA per reaction.
Specifications
Specifications
-
Catalog No.ON-1078
-
SourceRecombinant E.coli
-
Purity＞95% by SDS-PAGE
-
Storage Condition-20℃
Documentation
Documentation
Product Information
HiXT7 RNA Polymerase is a DNA-dependent RNA polymerase designed to increase co-transcriptional capping efficiency and reduce double-stranded RNA formation during IVT, enabling the production of high-quality, clean mRNA transcripts. This optimized enzyme is specifically suited for use with HiXCap E1, HiXCap E2, HiXCap E3 and M6 GAAG Cap2 cap analogs, delivering superior 5’-end capping performance compared with wild-type T7 RNA polymerase. The enzyme is fully compatible with 5×HIC IVT Reaction Buffer, and supports up to 100 µg of high-quality capped RNA per reaction.
-
Catalog No.ON-1078
-
SourceRecombinant E.coli
-
Purity＞95% by SDS-PAGE
-
Storage Condition-20℃
Why choose Hongene?
Trusted Partner in Nucleic Acid
Enjoy enterprise‑grade quality even with small batch orders.
Integrated Supply & Commercial Scale
With nearly 30 years of expertise, we control a secure supply chain for RNA raw materials and provide reliable GMP-grade oligo synthesis from research to commercial kilogram-scale production.
Proprietary Technology & IP
Our proprietary Chemoenzymatic Ligation Platform combines chemical andenzymatic methods, enabling high-putity, cost-effective, and large-scale production of RNA-based therapeutics.
Rigorous Quality
We implement multiple stringent QC steps, maintain ISO certifications, and ensure >99% batch-to-batch consistency, reducing scale-up and PPQ risks.
Manufacturing Scalability
Hongene operates a 1.67-million-square-foot oligonucleotide manufacturing facility featuring advanced equipment, including multiple OligoPilot™ and OligoProcess™ synthesizers ranging from 10 to 1,800 mmol. Its 48 flexible production lines enable seamless, one-stop scale-up of API production from gram-level quantities to metric tons, achieving purity of ≥98% while supporting compliance with NMPA, FDA, and EMA regulatory requirements.
Global Business Network
Our products and services reach over 40 countries and regions, supporting around 3,000 clients worldwide.
